Stay updated with breaking news from Cyprus Based Berhyanda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Suven Pharmaceuticals Ltd had reported a 12.2 percent year-on-year (YoY) rise in net profit at Rs 120.6 crore for the first quarter that ended June 30, 2023
Suven Pharmaceuticals Ltd had reported a 12.2 percent year-on-year (YoY) rise in net profit at Rs 120.6 crore for the first quarter that ended June 30, 2023
According to the latest shareholding pattern available with the exchanges, as of 30 June 2023, 60% of the company's shareholding is with the promoter & promoter group, and 40% with the public.
Suven Pharmaceuticals shares zoomed 8.53% to a fresh high of Rs 557.40 against the previous close of Rs 513.55 on BSE
The approval is for acquisition of up to 76.1% shares of Suven Pharmaceuticals by Berhyanda Limited.